Table 4 Comparison of immune function between the two groups
From: Safety and efficacy of precision hepatectomy in the treatment of primary liver cancer
Indicators | Time | Study group(49) | Controlgroup(49) | t | P |
|---|---|---|---|---|---|
CD4+(%) | Before surgery | 34.98 ± 3.87 | 35.01 ± 4.01 | -0.038 | 0.971 |
1 week after surgery | 27.02 ± 3.93 | 20.87 ± 3.87 | 7.792 | <0.001 | |
CD3+(%) | Before surgery | 62.09 ± 4.09 | 62.17 ± 3.16 | -0.108 | 0.914 |
1 week after surgery | 48.76 ± 4.21 | 53.29 ± 3.76 | -5.685 | <0.001 | |
CD4+/CD8+(%) | Before surgery | 1.31 ± 0.19 | 1.33 ± 0.21 | -0.494 | 0.622 |
1 week after surgery | 0.93 ± 0.16 | 0.64 ± 0.17 | -291.151 | <0.001 |